In the rapidly growing connected medical device market, technology directly impacts human lives; safety, data security and reliability are non-negotiable. Against this backdrop, Orange Business and MicroPort CardioFlow have further strengthened their long-term partnership for another five years to advance patient-centered digital health built on trust, resilience and uncompromising performance.
The connected medical device sector is projected to grow from US$87.17 billion this year to a staggering US$173.26 billion by 2031. This trend is fueled by an ageing population, expanding care-anywhere models and a shift toward precision medicine and individualised care. Through more than a decade of collaboration, Orange Business has supported MicroPort CardioFlow in expanding its global user base by approximately 20% year on year. Together, they aim to expand their share of the digital health market, emphasising trust at every level to boost the adoption of connected care technologies across clinical and patient settings.
MicroPort CardioFlow’s digital solution transmits clinical health data from implanted cardiac devices to healthcare professionals (HCPs) for monitoring and analysis. Trust in Orange Business’s technical capabilities and data protection has been mandatory from the outset of the collaboration. “We are delighted to extend our long-standing relationship with Orange Business,” said Hervé Gaillard, Director for Software and Services, R&D, MicroPort CardioFlow. “This partnership aligns perfectly with our mission to deliver superior, trusted, connected healthcare solutions that improve patients’ quality of life by providing clinicians with real-time data to monitor and aid faster, more accurate decision making.”
A secure global infrastructure for remote health monitoring
By leveraging strong e-health and integration capabilities, Orange Business provides the digital backbone for MicroPort CardioFlow’s remote cardiac monitoring system. Specifically, it provides a secure, scalable IoT platform and connectivity with data hosted in compliant data centres.
The Orange Business platform enables patient data and alert messages from MicroPort CardioFlow’s cardiac rhythm management (CRM) implantable devices, such as pacemakers, to be securely accessible by clinicians via a remote monitoring solution.
By leveraging the Orange global presence, MicroPort CardioFlow’s customers can trust that their data is handled securely and always transmitted with absolute integrity. The scalability and global reach of the Orange network also align with MicroPort CardioFlow’s global footprint
A secure end-to-end data journey
Orange Business currently secures the data journey for MicroPort CardioFlow’s SmartView ecosystem, protecting sensitive data and ensuring accurate, trustworthy data transmission for safe and effective clinical decisions. Orange Cyberdefense, the expert cybersecurity unit within Orange, provides penetration testing and security reports to make sure the environment is fully secured at all times.
The implanted device continually monitors the patient’s heart. It automatically ‘talks’ to the SmartView Connect bedside monitor using a Bluetooth low-energy connection. Secure outbound transmission can be done either automatically or upon request and the cellular module and SIM within the monitor authenticates the connection.
Data is encrypted in transit and matched to the correct clinical profile and once validated, stored according to regulatory compliance requirements. Raw data is then analysed and turned into clinically usable insights, which HCPs can view through a secure web portal to enable further decisions on patient follow-up.
Because patients and HCPs are often in different locations or even countries, Orange Business roaming SIMs can connect to multiple networks, giving connected, implanted devices reliable, cross-border connectivity needed for continuous monitoring. This alleviates the need for numerous routine visits to the hospital or clinic and also reassures patients that they are being monitored wherever they are.
Data sovereignty in global health compliance
As healthcare becomes increasingly digital and cross-border data expands, data sovereignty has become pivotal to compliance strategy. Orange Business supports MicroPort CardioFlow in managing regulatory risk effectively, providing a secure, localised and compliant infrastructure, maintaining trust with regulators, clinicians and patients.
Data sovereignty is a critical consideration for MicroPort CardioFlow because it mandates where health data is stored, processed and governed under local laws and with strict regulations. The company must navigate and be compliant with complex regulations across regions, including HIPAA in the US, which reinforces safeguards around storage, access and sharing of patient records and GDPR in Europe, which imposes strict requirements on consent, data minimisation and patient rights. In France, specifically, companies must obtain HDS certification, ensuring infrastructure and operational processes meet nationally defined security and privacy standards for hosting personal health data.
Looking to the future of connected health
MicroPort CardioFlow and Orange Business continue to explore future opportunities to enhance connected healthcare solutions through emerging technologies. As digital health evolves, both companies are evaluating innovative approaches that could further support personalised models aimed at improving clinical outcomes and expanding access to high-quality healthcare.
The future of healthcare, however, is not just digital – it is connected, intelligent and above all, human. Orange Business is committed to shaping this future by delivering secure, reliable connectivity that enables the seamless integration of AI-driven technologies. Its mission is to support more human-centric healthcare through trusted, transparent, real-time data solutions that help improve patient outcomes.
“Our trusted partnership with MicroPort CardioFlow elevates the customer experience and accelerates innovation from secure, always-on connectivity to clinical use,” said Claire Scotton, Vice President, Healthcare and Life Sciences at Orange Business. “This connection underpins the next generation of remote health monitoring, transforming healthcare and enabling end-to-end orchestration for MicroPort CardioFlow to provide even more precise, personalised care for chronic conditions.”
